Patients Patient involvement at NICE: In whose interest is it anyway? The National Institute for Health and Care Excellence (NICE) released a new
Views & Analysis Patient involvement in HTA Considering the essential role of patient experience in HTA and the role of pharma.
News Guidance creates access gap in UK for GPP drug Spevigo People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
